Our History

Jump to Year:

The foundation that began as three mothers around a kitchen table in 1988 is now the leading global nonprofit organization dedicated to eliminating pediatric HIV and AIDS. Browse this timeline to learn how it happened.

2014

EGPAF Today

EGPAF is currently supporting more than 7,000 sites around the world. Since EGPAF's international efforts began, EGPAF-supported programs have reached 20 million women with services to prevent the transmission of HIV to their babies; tested more than 17 million women for HIV; enrolled more than 2.2 million individuals, including more than 175,000 children, into HIV care and support programs; and started more than 1.2 million individuals, including more than 104,000 children, on antiretroviral treatment. (all data current through December 31, 2013)

Share this: facebook twitter

2014

20 Million Women Reached with PMTCT Services

In May, EGPAF announced that it has reached 20 million women with lifesaving services, such as HIV testing, counseling, and treatment, to prevent HIV-positive women from passing the virus to their babies. This accomplishment marks a significant milestone for EGPAF and the worldwide effort to achieve an AIDS-free generation.

Share this: facebook twitter

2014

Three-Year Anniversary of Affiliate Partnerships

The Elizabeth Glaser Pediatric AIDS Foundation marked the three-year anniversary of its partnerships with affiliated national HIV organizations in Côte d’Ivoire, Mozambique, and Tanzania. With funding from the U.S. Centers for Disease Control and Prevention (CDC), EGPAF launched its affiliate model in 2011 to respond to the growing need for a national, multi-stakeholder approach to the HIV/AIDS epidemic. Strengthening national organizations through affiliation is one component of EGPAF’s commitment to advancing country ownership in order to end AIDS in children.

Share this: facebook twitter

2013

Functional Cure of Mississippi Baby

The Elizabeth Glaser Pediatric AIDS Foundation applauds news of an infant being cured of HIV following a period of antiretroviral treatment that started within the first 30 hours of life. Announced at the 20th annual Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, the news is indicative of the continuing progress made by researchers and advocates in creating an AIDS-free generation. Led by researcher Deborah Persaud, winner of the Elizabeth Glaser Pediatric AIDS Foundation Scientist award in 2005, the study followed a Mississippi infant with a confirmed HIV diagnosis who received antiretroviral medications within 30 hours following birth. Now 26 months old, the baby shows no evidence of infection and is functionally cured of HIV.

Share this: facebook twitter

2011

Project HEART

Through the leadership and support of the President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Centers for Disease Control and Prevention (CDC), the Elizabeth Glaser Pediatric AIDS Foundation led the implementation of Project HEART (Help Expand Antiretroviral Therapy to children and families) in five countries over the past eight years. Project HEART was a groundbreaking initiative to extend life-saving HIV prevention, care, and treatment to millions of people living in sub-Saharan Africa. The Foundation launched Project HEART in 2004 in Côte d’Ivoire, South Africa, Tanzania, and Zambia, and in 2006 in Mozambique.

Share this: facebook twitter

2008

EGPAF Helps Renew PEPFAR

EGPAF helps renew the President’s Emergency Plan for AIDS Relief (PEPFAR), authorizing $48 billion in global health programs.

Share this: facebook twitter

2003

The Beginning of PEPFAR

The President’s Emergency Plan for AIDS Relief (PEPFAR) is launched, allowing EGPAF’s global work and reach to expand. Four years later, more than 25 percent of all HIV-positive pregnant women worldwide who receive medicine to prevent transmission of HIV to their babies do so through EGPAF-supported programs.

Share this: facebook twitter

1999

EGPAF Becomes a Part of the Global AIDS fight

EGPAF enters the global AIDS arena by beginning work to prevent mother-to-child transmission of HIV in six countries.

Share this: facebook twitter

1994

Elizabeth Glaser Passes Away

Elizabeth Glaser passes away from AIDS-related illnesses. It would take another nine years, but her vision for pediatric drug research would become a reality in 2003, when the U.S. Congress passes the Pediatric Research Equity Act. This new law dramatically increases the number of drugs tested and labeled for use in children.

Share this: facebook twitter

1992

Elizabeth Speaks at Democratic National Convention

Elizabeth Glaser speaks at the Democratic National Convention, drawing the attention of Americans to the issues facing people living with HIV.

Share this: facebook twitter

1991

Magic Johnson Announces HIV Status

Professional basketball player Earvin “Magic” Johnson announces his HIV-positive status and retires from the NBA. He credits Elizabeth Glaser with giving him the courage to speak out.

Share this: facebook twitter

1990

The Glasers ask U.S. Congress to Provide Funding

Elizabeth and Paul Glaser ask the U.S. Congress to provide funding to test HIV drugs in children. While AZT, a promising drug treatment, had already been approved by the FDA, its potential impact on children was still unknown due to a lack of research.

Share this: facebook twitter

1988

Foundation Begins

After losing Ariel at age seven to AIDS-related illness, Elizabeth creates the Pediatric AIDS Foundation with her friends Susie Zeegen and Susan DeLaurentis. Their goal: Give hope to children and families affected by HIV and AIDS.

Share this: facebook twitter

1981

Elizabeth Glaser contracts HIV through a blood transfusion during childbirth.

Elizabeth Glaser contracts HIV through a blood transfusion during childbirth. Elizabeth and her husband Paul later learn that she unknowingly passed the virus to her children, Ariel and Jake.

Share this: facebook twitter